SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-04-017767
Filing Date
2004-06-24
Accepted
2004-06-24 10:48:10
Documents
2
Period of Report
2004-06-22

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3792
2 EX-24 ex-24.htm EX-24 7250
  Complete submission text file 0001104659-04-017767.txt   12758
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Issuer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TRANSKARYOTIC THERAPIES INC 700 MAIN STREET CAMBRIDGE MA 02139
Business Address
GILBERT WALTER PHD (Reporting) CIK: 0001236368 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21481 | Film No.: 04878572